Skyworks Deserves A Higher Multiple
The big boost to revenue growth will come with 5G and this is still at least a year off. Despite handset saturation, the company can still win content and their […]
The big boost to revenue growth will come with 5G and this is still at least a year off. Despite handset saturation, the company can still win content and their […]
The company let customers navigate a labyrinthine US healthcare system, which seems an excellent business proposition to us. It has really considerable expansion opportunities and it is consolidating its different […]
The shares popped on a substantial order, and this came off the back of another substantial order a couple of weeks ago and good growth figures in Q3. But while […]
The Chinese economy is already slowing down, its stock market is crashing, its currency sinking and authorities are cracking down on leverage. And on top of that the US has […]
Management prefers growth over margins, and they are right to do so and can easily invest in growth, given their extremely solid balance sheet and cash generation. Yet, they haven’t […]
The company is on track with its three strategic initiatives to accelerate growth, convert to a subscription model, and expand margins. In the process, the biggest gains are actually in […]
Terrific acceleration at BioLife and it’s no surprise that the share price has gone parabolic. Revenue growth is accelerating, gross margins are increasing, there is a great deal of operational […]
The company grows at an impressive pace and we believe this is likely to continue as there are plenty of opportunities to add revenue streams. We are also not too […]
After some wobbles when trade tensions hit the headlines, the markets seem to have regained their footing. For some, this seems odd, given the all to real potential for a […]
The company’s shares have doubled in just three months, and it’s not hard to see why. The business model has multiple leverage points and they’re only starting to apply these […]